Methodist Health System

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Renal Autotransplantation; Case Series

Conditions: Renal Vascular Disease
Renal Tumor
Nutcracker Syndrome, Renal
Pelvic Trauma
Loin Pain-Hematuria Syndrome
Congestion, Venous

Interventions: Procedure: Pre-Operative Information
Procedure: Intra-Operative Data
Other: Post-Operative Data (up to discharge)
Other: Short-Term Follow-Up Data

First Posted Date: 2021-11-10

Last Posted Date: 2024-03-27

Lead Sponsor: Methodist Health System

Target Recruit Count: 30

Registration Number: NCT05115812

Locations: 🇺🇸
Liver Institute of Methodist Dallas Medical Center, Dallas, Texas, United States

Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases

Conditions: Gastrointestinal Disease

First Posted Date: 2021-11-10

Last Posted Date: 2024-03-27

Lead Sponsor: Methodist Health System

Target Recruit Count: 1000

Registration Number: NCT05115877

Locations: 🇺🇸
Methodist Richardson Medical Center, Richardson, Texas, United States

Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation

Completed

Conditions: Liver Transplant

Interventions: Procedure: Liver Transplantation

First Posted Date: 2021-10-21

Last Posted Date: 2023-10-18

Lead Sponsor: Methodist Health System

Target Recruit Count: 186

Registration Number: NCT05087550

Locations: 🇺🇸
The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, United States

Fetal Outcomes Among Pregnant Emergency General Surgery Patients

Conditions: Pregnancy Complications
Acute Appendicitis
Acute Cholecystitis
Biliary Pancreatitis
Acute Diverticulitis
Bowel Obstruction

First Posted Date: 2021-10-20

Last Posted Date: 2024-03-27

Lead Sponsor: Methodist Health System

Target Recruit Count: 50

Registration Number: NCT05085353

Locations: 🇺🇸
Trauma Center at Methodist Dallas Medical Center, Dallas, Texas, United States

Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and Hypotension

Withdrawn

Conditions: Hypotension
Cirrhosis

Interventions: Other: serum concentration of estrogen (E1 and E2) and testosterone ratio measurement

First Posted Date: 2021-09-21

Last Posted Date: 2023-10-19

Lead Sponsor: Methodist Health System

Registration Number: NCT05051293

Locations: 🇺🇸
Methodist Health System Clinical Research Institute, Dallas, Texas, United States

Natural History of Non Alcoholic Fatty Liver Disease and Predictors of Advanced Fibrosis

Withdrawn

Conditions: Non-alcoholic Steatohepatitis (NASH)

First Posted Date: 2021-09-20

Last Posted Date: 2021-12-13

Lead Sponsor: Methodist Health System

Registration Number: NCT05050721

Locations: 🇺🇸
The Liver Institute at Methodist Dallas Medical Center, Irving, Texas, United States

Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry.

Completed

Conditions: Bile Duct Cancer
Pancreas Cancer

Interventions: Procedure: Interventional Endoscopy procedures

First Posted Date: 2021-06-24

Last Posted Date: 2021-11-11

Lead Sponsor: Methodist Health System

Target Recruit Count: 8

Registration Number: NCT04937322

Locations: 🇺🇸
Methodist Dallas Medical Center, Dallas, Texas, United States

RELISTOR's Effects on Opioid-Induced Constipation

Withdrawn

Conditions: OIC

Interventions: Drug: Docusate Calcium
Drug: Relistor Injectable Product
Drug: Bisacodyl
Drug: Milk of magnesia
Drug: Magnesium citrate
Drug: Senna
Drug: Enema

First Posted Date: 2021-06-18

Last Posted Date: 2022-05-03

Lead Sponsor: Methodist Health System

Registration Number: NCT04930237

Locations: 🇺🇸
Methodist Moody Brain and Spine Institute, Methodist Dallas Medical Center, Dallas, Texas, United States

Antibiotic Use in Facial Fracture Post Injury

Recruiting

Conditions: Trauma Injury

Interventions: Drug: Antibiotics

First Posted Date: 2021-06-14

Last Posted Date: 2024-03-27

Lead Sponsor: Methodist Health System

Target Recruit Count: 1000

Registration Number: NCT04925531

Locations: 🇺🇸
Methodist Dallas Medical Center, Dallas, Texas, United States

Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC with Y90 SIR-Spheres

Completed

Conditions: Hepatocellular Carcinoma

First Posted Date: 2021-05-26

Last Posted Date: 2024-11-18

Lead Sponsor: Methodist Health System

Target Recruit Count: 1

Registration Number: NCT04903548

Locations: 🇺🇸
Methodist Dallas Medical Center, Dallas, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy